| 201 |
Evaluation of serum level of some angiogenic factors in
non hodgkin's lymphoma |
2012 |
| 202 |
Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations |
2012 |
| 203 |
Phase II study of high dose thoracic radiation therapy with concurrent cisplatin and etoposide in unresectable non small cell lung cancer. |
2012 |
| 204 |
Phase II study of high dose thoracic radiation therapy with concurrent cisplatin and etoposide in unresectable non small cell lung cancer. |
2012 |
| 205 |
Phase II study of high dose thoracic radiation therapy with concurrent cisplatin and etoposide in unresectable non small cell lung cancer. |
2012 |
| 206 |
Survival Results withe the Use of Chemoradiotherapy in the Treatment of Locally Advanced Non-Small Cell Lung Cancer |
2012 |
| 207 |
Des-gamma Carboxy Prothrombin, Alpha-Feto Protein and Alpha-Feto Protein L3 in Patients with Cirrhosis and Hepatocellular Carcinoma. |
2011 |
| 208 |
Effectiveness of combined Botulinum toxin, Electrical stimulation and Rehabilitation on the functional level of spastic arm. |
2011 |
| 209 |
GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. |
2011 |
| 210 |
GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. |
2011 |